3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Drug Withdrawal Symptoms

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with Drug Withdrawal Symptoms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hruby, VJ; Keresztes, AI; Largent-Milnes, TM; Roeske, WR; Tumati, S; Vanderah, TW; Varga, EV; Yamamoto, T	1

Other Studies

1 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Drug Withdrawal Symptoms

Article	Year
Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. European journal of pharmacology, 2012, Jun-05, Volume: 684, Issue:1-3 Topics: Analgesics, Opioid; Animals; Astrocytes; Biomarkers; CD11b Antigen; Hyperalgesia; Male; Microglia; Morphine; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome; Tryptophan; Tumor Necrosis Factor-alpha; Up-Regulation	2012

Article

Year

Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

European journal of pharmacology, 2012, Jun-05, Volume: 684, Issue:1-3

Topics: Analgesics, Opioid; Animals; Astrocytes; Biomarkers; CD11b Antigen; Hyperalgesia; Male; Microglia; Morphine; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome; Tryptophan; Tumor Necrosis Factor-alpha; Up-Regulation

2012